Differential apoptotic susceptibility to anti-Fas IgM and anticancer drugs in a human endometrial adenocarcinoma cell line HHUA on laminin and type I collagen

Osaka City Med J. 1998 Dec;44(2):173-80.

Abstract

Apoptotic susceptibility of epithelial cells is known to be regulated by cell adhesions to basement membranes. In this study differences in anticancer drug-sensitivities of early and advanced endometrial adenocarcinomas were examined by using highly-differentiated human endometrial adenocarcinoma cell line, HHUA, whose apoptotic susceptibility was hypothesized to be modulated by extracellular matrices. The cells express high levels of laminin receptors and laminin suppressed Fas-mediated apoptosis of the cells. However laminin did not show any effect on apoptotic susceptibility to 4 anticancer drugs. These results suggest that there is little variation in drug-sensitivity associated with disruption of endometrial stromal tissue, and that pathological staging of endometrial carcinoma is not likely to have any relation to drug sensitivity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma / pathology
  • Adenocarcinoma / physiopathology*
  • Antineoplastic Agents / pharmacology*
  • Apoptosis / drug effects*
  • Collagen / pharmacology
  • Drug Resistance
  • Endometrial Neoplasms / pathology
  • Endometrial Neoplasms / physiopathology*
  • Female
  • Humans
  • Immunoglobulin M / immunology
  • Immunoglobulin M / pharmacology*
  • Laminin / pharmacology*
  • Tumor Cells, Cultured
  • fas Receptor / immunology*

Substances

  • Antineoplastic Agents
  • Immunoglobulin M
  • Laminin
  • fas Receptor
  • Collagen